FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135304921> ?p ?o ?g. }

• W2135304921 endingPage "e21758" @default.
• W2135304921 startingPage "e21758" @default.
• W2135304921 abstract "The neuropathic glycosphingolipidoses are a subgroup of lysosomal storage disorders for which there are no effective therapies. A potential approach is substrate reduction therapy using inhibitors of glucosylceramide synthase (GCS) to decrease the synthesis of glucosylceramide and related glycosphingolipids that accumulate in the lysosomes. Genz-529468, a blood-brain barrier-permeant iminosugar-based GCS inhibitor, was used to evaluate this concept in a mouse model of Sandhoff disease, which accumulates the glycosphingolipid GM2 in the visceral organs and CNS. As expected, oral administration of the drug inhibited hepatic GM2 accumulation. Paradoxically, in the brain, treatment resulted in a slight increase in GM2 levels and a 20-fold increase in glucosylceramide levels. The increase in brain glucosylceramide levels might be due to concurrent inhibition of the non-lysosomal glucosylceramidase, Gba2. Similar results were observed with NB-DNJ, another iminosugar-based GCS inhibitor. Despite these unanticipated increases in glycosphingolipids in the CNS, treatment nevertheless delayed the loss of motor function and coordination and extended the lifespan of the Sandhoff mice. These results suggest that the CNS benefits observed in the Sandhoff mice might not necessarily be due to substrate reduction therapy but rather to off-target effects." @default.
• W2135304921 created "2016-06-24" @default.
• W2135304921 creator A5006099707 @default.
• W2135304921 creator A5013935159 @default.
• W2135304921 creator A5018176610 @default.
• W2135304921 creator A5019185950 @default.
• W2135304921 creator A5034711909 @default.
• W2135304921 creator A5050690317 @default.
• W2135304921 creator A5053653082 @default.
• W2135304921 creator A5057984337 @default.
• W2135304921 creator A5063202464 @default.
• W2135304921 creator A5069759535 @default.
• W2135304921 creator A5072401273 @default.
• W2135304921 creator A5079813508 @default.
• W2135304921 creator A5091409035 @default.
• W2135304921 date "2011-06-29" @default.
• W2135304921 modified "2023-10-06" @default.
• W2135304921 title "Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease" @default.
• W2135304921 cites W1968758382 @default.
• W2135304921 cites W1971710874 @default.
• W2135304921 cites W1979226485 @default.
• W2135304921 cites W1988193452 @default.
• W2135304921 cites W1988843643 @default.
• W2135304921 cites W1997871795 @default.
• W2135304921 cites W1998763644 @default.
• W2135304921 cites W1999671145 @default.
• W2135304921 cites W2002311959 @default.
• W2135304921 cites W2011501261 @default.
• W2135304921 cites W2019839083 @default.
• W2135304921 cites W2022857037 @default.
• W2135304921 cites W2027065209 @default.
• W2135304921 cites W2027459860 @default.
• W2135304921 cites W2029965274 @default.
• W2135304921 cites W2032495622 @default.
• W2135304921 cites W2034955397 @default.
• W2135304921 cites W2041126270 @default.
• W2135304921 cites W2042512150 @default.
• W2135304921 cites W2043642541 @default.
• W2135304921 cites W2044534774 @default.
• W2135304921 cites W2045414227 @default.
• W2135304921 cites W2056703046 @default.
• W2135304921 cites W2062899231 @default.
• W2135304921 cites W2067723689 @default.
• W2135304921 cites W2072437381 @default.
• W2135304921 cites W2076585244 @default.
• W2135304921 cites W2077022748 @default.
• W2135304921 cites W2080911273 @default.
• W2135304921 cites W2081665969 @default.
• W2135304921 cites W2083102048 @default.
• W2135304921 cites W2090051116 @default.
• W2135304921 cites W2099717197 @default.
• W2135304921 cites W2106244437 @default.
• W2135304921 cites W2109368575 @default.
• W2135304921 cites W2113501570 @default.
• W2135304921 cites W2122810522 @default.
• W2135304921 cites W2124007806 @default.
• W2135304921 cites W2126057638 @default.
• W2135304921 cites W2128541330 @default.
• W2135304921 cites W2128631317 @default.
• W2135304921 cites W2130630186 @default.
• W2135304921 cites W2134096822 @default.
• W2135304921 cites W2136689144 @default.
• W2135304921 cites W2146180881 @default.
• W2135304921 cites W2148391445 @default.
• W2135304921 cites W2157900484 @default.
• W2135304921 cites W2163527490 @default.
• W2135304921 cites W2171954574 @default.
• W2135304921 doi "https://doi.org/10.1371/journal.pone.0021758" @default.
• W2135304921 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3126858" @default.
• W2135304921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21738789" @default.
• W2135304921 hasPublicationYear "2011" @default.
• W2135304921 type Work @default.
• W2135304921 sameAs 2135304921 @default.
• W2135304921 citedByCount "55" @default.
• W2135304921 countsByYear W21353049212012 @default.
• W2135304921 countsByYear W21353049212013 @default.
• W2135304921 countsByYear W21353049212014 @default.
• W2135304921 countsByYear W21353049212015 @default.
• W2135304921 countsByYear W21353049212016 @default.
• W2135304921 countsByYear W21353049212017 @default.
• W2135304921 countsByYear W21353049212018 @default.
• W2135304921 countsByYear W21353049212019 @default.
• W2135304921 countsByYear W21353049212020 @default.
• W2135304921 countsByYear W21353049212021 @default.
• W2135304921 countsByYear W21353049212022 @default.
• W2135304921 countsByYear W21353049212023 @default.
• W2135304921 crossrefType "journal-article" @default.
• W2135304921 hasAuthorship W2135304921A5006099707 @default.
• W2135304921 hasAuthorship W2135304921A5013935159 @default.
• W2135304921 hasAuthorship W2135304921A5018176610 @default.
• W2135304921 hasAuthorship W2135304921A5019185950 @default.
• W2135304921 hasAuthorship W2135304921A5034711909 @default.
• W2135304921 hasAuthorship W2135304921A5050690317 @default.
• W2135304921 hasAuthorship W2135304921A5053653082 @default.
• W2135304921 hasAuthorship W2135304921A5057984337 @default.
• W2135304921 hasAuthorship W2135304921A5063202464 @default.
• W2135304921 hasAuthorship W2135304921A5069759535 @default.
• W2135304921 hasAuthorship W2135304921A5072401273 @default.

• next